Trial tests new way to stop bleeding in tiny hearts
NCT ID NCT04376762
Summary
This study compared two different treatments to help control serious bleeding in babies under 2 years old after heart surgery. Researchers tested a purified protein powder (fibrinogen concentrate) against a standard blood product (cryoprecipitate) to see which one was better at helping blood clot. The goal was to reduce the need for additional blood transfusions and improve recovery for these high-risk infants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEEDING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia Health System
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.